What are Acadia Pharmaceuticals's profit margins?

Acadia Pharmaceuticals (ACAD) runs a 91.5% gross margin and a 7.4% operating margin, with a 34.3% net margin.

Where do Acadia Pharmaceuticals's ratios come from?

Every ratio is computed from Acadia Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Acadia Pharmaceuticals ACAD Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	91.5%-0.6pp	91.7%+0.2pp	91.9%+0.3pp	92%+0.2pp	92%-0.2pp
Operating margin	7.4%-16.2pp	9.8%-14.3pp	23%—	23.2%—	23.6%—
Net margin	34.3%+11.3pp	36.5%+12.8pp	24.9%+11.1pp	21.8%+18.4pp	23%+23.2pp
EBITDA margin	8.5%-16.4pp	10.9%-14.9pp	24.4%—	24.6%—	24.9%—
Returns
Return on equity	37.3%+0.1pp	39.9%+1.0pp	35%+7.6pp	33.2%+26.5pp	37.2%+37.6pp
Return on assets	27.4%+4.4pp	28.4%+5.0pp	22.6%+6.7pp	20.8%+16.8pp	23%+23.3pp
Return on invested capital	10%-34.0pp	13.4%-39.5pp	38.8%—	38.4%—	44%—
Efficiency
Asset turnover	0.8×-0.2×	0.8×-0.2×	0.9×-0.2×	1×-0.2×	1×-0.1×
Liquidity
Current ratio	3.6×+0.7×	3.8×+1.5×	3×+0.7×	2.9×+0.8×	2.9×+0.8×
Quick ratio	3.6×+0.7×	3.8×+1.5×	3×+0.7×	2.9×+0.8×	2.8×+0.9×
Cash ratio	0.9×+0.2×	0.6×-0.2×	0.7×+0.3×	0.8×+0.2×	0.7×+0.1×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0.1×0.0×	0.1×0.0×	0.1×-0.1×
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Net debt / EBITDA	-2.5×-1.8×	-1.1×0.0×	-0.8×—	-0.8×—	-0.7×—
Interest coverage	2.5×-5.9×	3.3×-5.8×	7.9×—	8.2×—	8.4×—
Per Share
Book value per share	$7.23+58.3%	$7.22+64.0%	$5.38+54.8%	$4.88+56.8%	$4.56+63.9%
Valuation
Market capitalization	$3.8B+37.0%	$4.52B+48.0%	$3.6B+41.1%	$3.75B+39.7%	$2.77B-9.1%
Enterprise value	$3.56B+36.6%	$4.39B+57.7%	$3.4B+38.9%	$3.55B+38.5%	$2.61B-10.1%
Price / earnings	10.1×-2.0×	11.6×-1.9×	13.8×-6.1×	16.9×-71.0×	12.1×—
Price / sales	3.5×+0.7×	4.2×+1.0×	3.4×+0.7×	3.7×+0.7×	2.8×-1.0×
Price / book	3×-0.6×	3.7×-0.5×	3.9×-0.5×	4.6×-0.6×	3.6×-2.9×
EV / EBITDA	38.4×+27.9×	37.7×+26.4×	13.3×—	14.2×—	10.5×—
EV / sales	3.3×+0.6×	4.1×+1.2×	3.2×+0.6×	3.5×+0.6×	2.6×-0.9×
Earnings yield	9.9%+1.6pp	8.7%+1.2pp	7.3%+2.2pp	5.9%+4.8pp	8.3%+8.3pp
PEG ratio	0.2×—	0.2×—	0.1×—	0×—	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Acadia Pharmaceuticals's profit margins?: Acadia Pharmaceuticals (ACAD) runs a 91.5% gross margin and a 7.4% operating margin, with a 34.3% net margin.
Where do Acadia Pharmaceuticals's ratios come from?: Every ratio is computed from Acadia Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.